Xanthohumol
- Generic Name
- Xanthohumol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H22O5
- CAS Number
- 6754-58-1
- Unique Ingredient Identifier
- T4467YT1NT
- Background
Xanthohumol is under investigation in clinical trial NCT01367431 (Xanthohumol and Metabolic Syndrome).
- Associated Conditions
- -
- Associated Therapies
- -
A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- National University of Natural Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT04590508
- Locations
- ๐บ๐ธ
National University of Natural Medicine, Portland, Oregon, United States
Xanthohumol Metabolism and Signature
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2018-11-08
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- National University of Natural Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT03735420
- Locations
- ๐บ๐ธ
Helfgott Research Institute National University of Natural Medicine, Portland, Oregon, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2024. All Rights Reserved by MedPath